Avant Healthcare
Network-owned
Address
630 W Carmel Drive
Carmel, Indiana 46032
Web Address
Year Founded
1994
Full-time Employees
197
Number of Clients
27
North American Revenue 2021
Full-time Employees 2021
Number of clients 2021
Offices
North America
1
Locations
Carmel, IN
Executives & Senior Management
Arun Divakaruni
CEO
Senior Management
Deborah Wood
Founder
Trina Stonner
President, Avant Healthcare Marketing
Todd Wright
President, Avant Healthcare Solutions
Rob Spalding
Chief Strategy and Marketing Officer
Patrick Kelley
Chief Creative Officer
Sean Markwardt
Vice President, Medical Affairs
Philippe Vitat
Vice President, Medical
Kat Barrett
Chief Operating Officer
Steven Hagnell
Chief Financial Officer
Marc Vorhees
Executive Director, Analytics
Arun Divakaruni
CEO
Agency 100 Book Cover
Capabilities/Services Offered
Professional
Direct Marketing
Med-ed
Payer
Med-Tech
Data/Analytics
Digital
New Services
Avant Healthcare has launched a Medical Affairs Center of Excellence, specifically designed and reserved for solving the unique challenges of Medical Affairs, applying our breadth of experience and methodology behind scientific insight, analysis, and innovation to mobilize and support the expanding value of our customer's organization.
Client Roster
Cannot disclose client/brand names, per MSA agreements
Growth
2021 Growth from Existing Clients
8%
2021 Growth from New Clients
12%
Trends and Challenges
Talent acquisition/retention
Managing growth
Getting an audience, virtually or otherwise, with HCPs
Keeping up with pace of innovation
Further diversification of services
Pandemic-related disruptions
Healthcare Marketing Trends
More personalization of communications
Need to create more/better content/experiences
Heightened focus on payers
Increased concern over drug pricing
Industry consolidation
Scrutiny around social media
Impact of empowered patients/consumers
Intensified focus on analytics/ROI/measurement
Decreased impact of sales forces
Regulatory changes
Programs that go “beyond the pill”
Evolution of EHRs
Emphasis on specialty drugs/high-science categories
Adopting a data-science culture
More digital experimentation
Seizing opportunities around cannabis
Working from home
Ongoing fallout from pandemic
Creative Samples
